<DOC>
	<DOCNO>NCT00511316</DOCNO>
	<brief_summary>Evaluate clinical effectiveness oral montelukast compare placebo prevention dysphagia food impaction patient EE . Also evaluate tolerance safety oral montelukast treatment EE .</brief_summary>
	<brief_title>Trial Montelukast Eosinophilic Esophagitis</brief_title>
	<detailed_description>We randomize double blind manner 60 consecutive consenting patient evaluate three Mayo Clinic Medical Centers EE montelukast 20mg daily placebo daily six month ? time . Patients remission treatment topical fluticasone therapy enrollment . Patients fill validate dysphagia side effect questionnaire , , end therapy .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>18 year age old &gt; 14 eosinophil / hpf biopsy mid esophagus within 6 month . Abnormal dysphagia questionnaire ( Question 1a yes , question 1c &gt; /= mild question 2 &gt; /= le week ) prior topical steroid treatment . This questionnaire recently validate . Normal dysphagia questionnaire topical steroid treatment ( Having answer question 1a : Have trouble swallowing , associate cold symptom ? past two week since complete swallowed steroid treatment ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>